Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Duncan F Moore

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of Scleroderma and Related Disorders|April 6, 2022
Overall mortalityDuncan F Moore, Virginia D Steen
Rheumatic Diseases Clinics of North America|September 28, 2020
Racial Disparities in Systemic SclerosisDuncan F Moore, Virginia D Steen
Arthritis Care & Research|September 11, 2023
Prevalence and Characteristics of Patients With Systemic Sclerosis Fulfilling the 2019 EULAR/American College of Rheumatology Classification Criteria for Systemic Lupus ErythematosusRonald D Bass, Duncan F Moore, Virginia D Steen
Arthritis Care & Research|March 2, 2019
Increased Morbidity and Mortality of Scleroderma in African Americans Compared to Non-African AmericansDuncan F Moore, Elisabeth Kramer, Rami Eltaraboulsi, et al.
JAAD Case Reports|March 21, 2022
A case of generalized morphea profunda following SARS-CoV-2 infectionMichael R Stephens, Duncan F Moore, Jonathan Dau, et al.
Medrxiv : the Preprint Server for Health Sciences|June 12, 2025
Machine Learning Analysis of Electronic Health Records Identifies Interstitial Lung Disease and Predicts Mortality in Patients with Systemic SclerosisAlec K Peltekian, Kevin M Grudzinski, Bradford C Bemiss, et al.
Rheumatology (Oxford, England)|April 20, 2023
CONQUER Scleroderma: association of gastrointestinal tract symptoms in early disease with resource utilizationSarah Luebker, Tracy M Frech, Shervin Assassi, et al.
Annals of the American Thoracic Society|April 10, 2025
Use of Nintedanib for the Treatment of Systemic Sclerosis-associated Interstitial Lung Disease at Expert Scleroderma Centers in the United StatesYiming Luo, Shervin Assassi, Maureen D Mayes, et al.
The Journal of Rheumatology|January 15, 2025
Psychometric Evaluation of the Scleroderma Skin Questionnaire: A Novel Patient-Reported Outcome for Skin Disease in Patients With Systemic SclerosisJeong Min Yu, John M VanBuren, Angela Child, et al.
The Journal of Rheumatology|November 15, 2025
Type III and type VI collagen neoepitopes are associated with disease severity in systemic sclerosisAli Y Ayla, Elana J Bernstein, Meng Zhang, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of Scleroderma and Related Disorders|April 6, 2022
Overall mortalityDuncan F Moore, Virginia D Steen
Rheumatic Diseases Clinics of North America|September 28, 2020
Racial Disparities in Systemic SclerosisDuncan F Moore, Virginia D Steen
Arthritis Care & Research|September 11, 2023
Prevalence and Characteristics of Patients With Systemic Sclerosis Fulfilling the 2019 EULAR/American College of Rheumatology Classification Criteria for Systemic Lupus ErythematosusRonald D Bass, Duncan F Moore, Virginia D Steen
Arthritis Care & Research|March 2, 2019
Increased Morbidity and Mortality of Scleroderma in African Americans Compared to Non-African AmericansDuncan F Moore, Elisabeth Kramer, Rami Eltaraboulsi, et al.
JAAD Case Reports|March 21, 2022
A case of generalized morphea profunda following SARS-CoV-2 infectionMichael R Stephens, Duncan F Moore, Jonathan Dau, et al.
Medrxiv : the Preprint Server for Health Sciences|June 12, 2025
Machine Learning Analysis of Electronic Health Records Identifies Interstitial Lung Disease and Predicts Mortality in Patients with Systemic SclerosisAlec K Peltekian, Kevin M Grudzinski, Bradford C Bemiss, et al.
Rheumatology (Oxford, England)|April 20, 2023
CONQUER Scleroderma: association of gastrointestinal tract symptoms in early disease with resource utilizationSarah Luebker, Tracy M Frech, Shervin Assassi, et al.
Annals of the American Thoracic Society|April 10, 2025
Use of Nintedanib for the Treatment of Systemic Sclerosis-associated Interstitial Lung Disease at Expert Scleroderma Centers in the United StatesYiming Luo, Shervin Assassi, Maureen D Mayes, et al.
The Journal of Rheumatology|January 15, 2025
Psychometric Evaluation of the Scleroderma Skin Questionnaire: A Novel Patient-Reported Outcome for Skin Disease in Patients With Systemic SclerosisJeong Min Yu, John M VanBuren, Angela Child, et al.
The Journal of Rheumatology|November 15, 2025
Type III and type VI collagen neoepitopes are associated with disease severity in systemic sclerosisAli Y Ayla, Elana J Bernstein, Meng Zhang, et al.
Pageof 2